Li et al. demonstrated that IGF2BP3 is involved in m6A-regulated PDK4 mRNA stability, thereby regulating cervical cancer cell proliferation, glycolysis, and sensitivity to doxorubicin treatment [141]. The gene discussed is IGF2BP3; the disease is cervical cancer.